Literature DB >> 19621257

Protective and antioxidative effects of GM1 ganglioside in PC12 cells exposed to hydrogen peroxide are mediated by Trk tyrosine kinase.

Natalia F Avrova1, Tatyana V Sokolova, Yulia A Vlasova, Irina O Zakharova, Victor V Furaev, Maria P Rychkova.   

Abstract

GM1 ganglioside was found to increase the survival of PC12 cells exposed to H(2)O(2), its action was blocked by Trk tyrosine kinase inhibitor K-252a. Thus, the inhibition of H(2)O(2) cytotoxic action by GM1 constituted 52.8 +/- 4.3%, but in the presence of 1.0 microM K-252a it was only 11.7 +/- 10.8%, i.e. the effect of GM1 became insignificant. Exposure to GM1 markedly reduced the increased accumulation of reactive oxygen species (ROS) and diminished the inactivation of Na(+),K(+)-ATPase induced in PC12 cells by H(2)O(2), but in the presence of K-252a GM1 did not change these metabolic parameters. The inhibitors of extracellular signal-regulated protein kinase, phosphatidyl inositol 3-kinase and protein kinase C decreased the effects of GM1. A combination of these protein kinase inhibitors reduced inhibition of H(2)O(2) cytotoxic action by GM1 to the larger extent than each of the inhibitors and practically abolished the ability of GM1 to decrease H(2)O(2)-induced ROS accumulation. The protective and antioxidative effects of GM1 in PC12 cells exposed to H(2)O(2) appear to be mediated by activation of Trk receptor tyrosine kinase and the protein kinases downstream from this enzyme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19621257     DOI: 10.1007/s11064-009-0033-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  41 in total

1.  Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid.

Authors:  Yasuji Matsuoka; Mitsuo Saito; John LaFrancois; Mariko Saito; Kate Gaynor; Vicki Olm; Lili Wang; Evelyn Casey; Yifan Lu; Chiharu Shiratori; Cynthia Lemere; Karen Duff
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

Review 2.  Gangliosides for acute ischemic stroke.

Authors:  Livia Candelise; Alfonso Ciccone
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

3.  Promotion of neurite outgrowth by protein kinase inhibitors and ganglioside GM1 in neuroblastoma cells involves MAP kinase ERK1/2.

Authors:  D W Singleton; C L Lu; R Colella; F J Roisen
Journal:  Int J Dev Neurosci       Date:  2000-12       Impact factor: 2.457

4.  Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage.

Authors:  Masamitsu Shimazawa; Tetsumori Yamashima; Neeraj Agarwal; Hideaki Hara
Journal:  Brain Res       Date:  2005-08-16       Impact factor: 3.252

5.  Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients.

Authors:  L E Augustinsson; K Blennow; C Blomstrand; G Bråne; R Ekman; P Fredman; I Karlsson; M Kihlgren; W Lehmann; A Lekman; J E Månsson; I Ramström; A Wallin; C Wikkelsö; C G Gottfries; L Svennerholm
Journal:  Dement Geriatr Cogn Disord       Date:  1997 Jan-Feb       Impact factor: 2.959

6.  Susceptibility of cerebellar granule neurons from GM2/GD2 synthase-null mice to apoptosis induced by glutamate excitotoxicity and elevated KCl: rescue by GM1 and LIGA20.

Authors:  Gusheng Wu; Zi-Hua Lu; Xin Xie; Robert W Ledeen
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

7.  Prevention of apoptotic neuronal death by GM1 ganglioside. Involvement of Trk neurotrophin receptors.

Authors:  G Ferrari; B L Anderson; R M Stephens; D R Kaplan; L A Greene
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

8.  GM1 ganglioside prevents seizures, Na+,K+-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole.

Authors:  Michele Rechia Fighera; Luiz Fernando Freire Royes; Ana Flávia Furian; Mauro Schneider Oliveira; Natália Gindri Fiorenza; Roberto Frussa-Filho; João Carlos Petry; Rafael Correa Coelho; Carlos Fernando Mello
Journal:  Neurobiol Dis       Date:  2006-03-03       Impact factor: 5.996

9.  Alzheimer disease - effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme.

Authors:  Lars Svennerholm; Görel Bråne; Ingvar Karlsson; Annika Lekman; Ingalill Ramström; Carsten Wikkelsö
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

10.  Activation of MAPK and CREB by GM1 induces survival of RGCs in the retina with axotomized nerve.

Authors:  Jun-Sub Choi; Jeong-A Kim; Choun-Ki Joo
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-04       Impact factor: 4.799

View more
  4 in total

1.  Disialogangliosides and TNFα alter gene expression for cytokines and chemokines in primary brain cell cultures.

Authors:  Donna M Byers; John C Gorbet; Louis N Irwin
Journal:  Neurochem Res       Date:  2011-10-01       Impact factor: 3.996

2.  Expression of tyrosine kinase receptors in cultured dorsal root ganglion neurons in the presence of monosialoganglioside and skeletal muscle cells.

Authors:  Hao Li; Weiwei Zhang; Guixiang Liu; Jianmin Li; Huaxiang Liu; Zhenzhong Li
Journal:  J Muscle Res Cell Motil       Date:  2012-09-12       Impact factor: 2.698

3.  GM1 ganglioside activates ERK1/2 and Akt downstream of Trk tyrosine kinase and protects PC12 cells against hydrogen peroxide toxicity.

Authors:  Irina O Zakharova; Tatyana V Sokolova; Yulia A Vlasova; Victor V Furaev; Maria P Rychkova; Natalia F Avrova
Journal:  Neurochem Res       Date:  2014-09-13       Impact factor: 3.996

Review 4.  Protective effects of exogenous gangliosides on ROS-induced changes in human spermatozoa.

Authors:  Mirjana Gavella; Vaskresenija Lipovac
Journal:  Asian J Androl       Date:  2013-03-18       Impact factor: 3.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.